Literature DB >> 12476782

Immunoregulatory effects of L-arginine and therapeutical implications.

M A Potenza1, C Nacci, D Mitolo-Chieppa.   

Abstract

Arginine, initially classified as a non-essential amino acid, participates to multiple biological processes including release of several hormones, collagen synthesis during wound healing, antitumor and antibacterial activities and non-specific immunity. Nitric oxide synthase and arginase competes for L-arginine as a substrate and this event appears to play a key role in the regulation of the inflammatory process. In this framework recent studies have identified complex patterns of interactions among these enzymes. This review will emphasizes some effects of L-arginine on immune cell functions, including triggering of L-arginine-nitric oxide and arginase pathways, its biological properties and therapeutical applications.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12476782     DOI: 10.2174/1568008013341811

Source DB:  PubMed          Journal:  Curr Drug Targets Immune Endocr Metabol Disord        ISSN: 1568-0088


  7 in total

1.  Modulating Oxidative Stress and Inflammation in Elders: The MOXIE Study.

Authors:  Amy Cameron Ellis; Tanja Dudenbostel; Julie L Locher; Kristi Crowe-White
Journal:  J Nutr Gerontol Geriatr       Date:  2016 Oct-Dec

2.  Oral Supplementation with Beta-Hydroxy-Beta-Methylbutyrate, Arginine, and Glutamine Improves Lean Body Mass in Healthy Older Adults.

Authors:  Amy C Ellis; Gary R Hunter; Amy M Goss; Barbara A Gower
Journal:  J Diet Suppl       Date:  2018-04-19

3.  L-arginine and Alzheimer's disease.

Authors:  Jing Yi; Laura L Horky; Avi L Friedlich; Ying Shi; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

4.  Interest of preoperative immunonutrition in liver resection for cancer: study protocol of the PROPILS trial, a multicenter randomized controlled phase IV trial.

Authors:  Oriana Ciacio; Thibault Voron; Gabriella Pittau; Maité Lewin; Eric Vibert; René Adam; Antonio Sa Cunha; Daniel Cherqui; Astrid Schielke; Olivier Soubrane; Olivier Scatton; Chady Salloum; Daniel Azoulay; Stéphane Benoist; Perrine Goyer; Jean-Christophe Vaillant; Laurent Hannoun; Emmanuel Boleslawski; Hélène Agostini; Didier Samuel; Denis Castaing
Journal:  BMC Cancer       Date:  2014-12-18       Impact factor: 4.430

5.  Comprehensive metabolic profiling of chronic low-grade inflammation among generally healthy individuals.

Authors:  Maik Pietzner; Anne Kaul; Ann-Kristin Henning; Gabi Kastenmüller; Anna Artati; Markus M Lerch; Jerzy Adamski; Matthias Nauck; Nele Friedrich
Journal:  BMC Med       Date:  2017-11-30       Impact factor: 8.775

6.  Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH).

Authors:  Lucinda Billingham; Neil Steven; Jennifer Pascoe; Aimee Jackson; Charlotte Gaskell; Claire Gaunt; Joyce Thompson
Journal:  BMC Cancer       Date:  2021-07-12       Impact factor: 4.430

7.  Effects of 6-month supplementation with β-hydroxy-β-methylbutyrate, glutamine and arginine on vascular endothelial function of older adults.

Authors:  A C Ellis; M Patterson; T Dudenbostel; D Calhoun; B Gower
Journal:  Eur J Clin Nutr       Date:  2015-08-26       Impact factor: 4.016

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.